Abstract
Objectives
To document bone mineral density of children and adolescents with cystic fibrosis.
Design
Cross-sectional study.
Setting
Tertiary-care center of Northern India, July 2012 to August 2015.
Participants
52 children aged 6-18 years with cystic fibrosis and 62 healthy controls of similar age and sex.
Methods
Both patients and controls were stratified into two groups, as pre-pubertal and peri-/post-pubertal, and compared for whole body bone mineral density, measured using dual energy X-ray absorptiometry. Serum levels of calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D and parathyroid hormone were measured in children with cystic fibrosis.
Results
Compared with controls, the mean (SD) bone mineral density of children with cystic fibrosis was significantly lower in both the pre-pubertal (0.7 (0.1) g/cm2 vs 0.9 (0.1) g/cm2; P<0.001)) and peri-/post-pubertal groups (0.9 (0.1) g/cm2 vs 1.1 (0.1) g/cm2; P<0.001). Also, the mean (SD) bone mineral apparent density of pre-pubertal and peri-/post-pubertal cystic fibrosis patients was lower than the controls (P<0.001 and P= 0.01, respectively). Thirty-seven (71.2%) cystic fibrosis patients had serum 25-hydroxyvitamin D level below 15 ng/mL.
Conclusion
Bone mineral density of children with cystic fibrosis was significantly lower than controls; majority of them were vitamin-D deficient. Intervening at an early stage of the disease and providing optimal therapy involving simultaneous management of the several factors affecting bone mineral accretion may be beneficial in improving bone health of these patients.
Similar content being viewed by others
References
Cystic Fibrosis Trust, 2007. Bone mineralization in cystic fibrosis. Report of the UK Cystic Fibrosis Trust Bone Mineralisation Working group. Bromley, London; Cystic Fibrosis Trust.
Kabra SK, Kabra M, Lodha R, Shastri S. Cystic fibrosis in India. Pediatr Pulmonol. 2007;42:1087–94.
Kabra SK, Kabra M, Shastri S, Lodha R. Diagnosing and managing cystic fibrosis in the developing world. Paediatr Respir Rev. 2006;7S:S147–50.
Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, Niven RM, et al. Low bone mineral density in adults with cystic fibrosis. Thorax. 1999; 54:961–7.
Conway SP, Morton AM, Oldroyd B, Truscott JG, White H, Smith AH, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000;55:798–804.
Elkin SL, Fairney A, Burnett S, Kemp M, Kyd P, Burgess J, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: A cross-sectional study. Osteoporos Int. 2001;12:366–72.
WHO Anthroplus software version 1.0.4 (based on WHO growth reference 2007 for 2009)). Available from: http:/www.who.int/childgrowth/software/en. Accessed January 12, 2015.
Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:172–9.
Katzman DK, Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescents girls. J Clin Endocrinol Metab. 1991;73:1332–9.
Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: Review of current knowledge and recommendations. Pediatrics. 2008;122:398–417.
Millar MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.
Hay JA, Cairney J. Development of the Habitual Activity Estimation scale for clinical research: A systematic approach. Pediatr Exer Sci. 2006;18:193–202.
Hardin DS, Arumugam R, Seilheimer DK, LeBlanc A, Ellis KJ. Normal bone mineral density in cystic fibrosis. Arch Dis Child. 2001;84:363–8.
Buntain HM, Greer RM, Schluter PJ, Wong JCH, Batch JA, Potter JM, et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: A controlled cross sectional study. Thorax. 2004;59:149–55.
Ujhelyi R, Treszl A, Vásárhelyi B, Holics K, Tóth M, Arató A, et al. Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: A follow-up study. J Pediatr Gastroenterol Nutr. 2004;38:401–6.
Grey V, Atkinson S, Drury D, Casey L, Ferland G, Gundberg C, et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics. 2008;122:1014–20.
Ashavaid TF, Raghavan R, Dhairyawan P, Bhawalkar S. Cystic fibrosis in India: A systematic review. J Assoc Physicians India. 2012;60:39–41.
Boucher GP, Lands LC, Hay JA, Hornby L. Activity levels and the relationship to lung function and nutritional status in children with cystic fibrosis. Am J Phy Med Rehab. 1997;76:311–5.
Shastri SS, Kabra M, Kabra SK, Pandey RM, Menon PS. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. J Cyst Fibros. 2008;7:110–5.
Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int. 2002;13:151–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, S., Mukherjee, A., Khadgawat, R. et al. Bone mineral density of Indian children and adolescents with cystic fibrosis. Indian Pediatr 54, 545–549 (2017). https://doi.org/10.1007/s13312-017-1065-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-017-1065-7